111
Views
2
CrossRef citations to date
0
Altmetric
Original Article

Importance of Early and Continuous Use of Protein Restriction on the Progression of Adriamycin Nephropathy

&
Pages 603-613 | Published online: 07 Jul 2009
 

Abstract

Three experimental protocols were carried out with the aim of evaluating the role of protein restriction on the progression of the established adriamycin-induced nephropathy, and whether the protective effect of the diet persists after the diet is discontinued. The effect of a low protein diet (LPD) was studied for 6 weeks in protocol 1, 16 weeks in protocol 2 and for 28 weeks in protocol 3. In protocol 3, one group (LL) received LPD and another (NN) was given a normal protein diet (NPD). A third group (LN) received LPD for 16 weeks and then NPD for 12 weeks and a fourth group (NL) was fed NPD for 16 weeks and then LPD for 12 weeks. In protocol 1 the tubulo-interstitial index (TILI) of rots on LPD (Md = 2, P25 = 0.0; P75 = 3.5) after six weeks, was smaller than that of the animals on NPD (Md = 60; P25 = 3.0; P75 = 8.0; p 0.0,5;. In protocol 2, the group taking LPD presented an area of interstitial fihrosis (IF) (Md 0.5%, P25 0.2%; P75 = 1.9%) smaller than that of the NPD group (Md = 6.8%; P25 = 5.2%; P75 = 7.1%; p < 0.05). No significant difference in the area of glomerulosclerosis (GSA) was observed between the animals on LPD (Md = 0.0%; P25 = 0.0%, P75 = 0.0%) and NPD (Md = 0.37%; P25 = 02%, P75 = 1.25%; p > 0.05). In protocol 3, the group LL showed GSA (Md = 1.3%; P25 0.6%, P75 = 2.5%; and IF (Md = 3.6%; P25 = 1.6%; P75 = 5.9%; smaller that those of LN (GSA Md = 10.1%; P25 = 6.6%; P75 = 14.8%; IF:Md = 17.3%; P25 = 14.1%; P75 = 24.5%), NL (GSA:Md = 9.1%; P25 = 5.8%; P75 = 11.7%; IF:Md = 25.0%; P25 = 20.4%; P75 = 50%), and NN (GSA:Md = 6.75%; P25 = 4.9%; P75 = 11.7%; IF:Md = 20.9%; P25 = 16.2%; P75 = 32.4%). In conclusion, in order to be effective, LPD must be introduced early and maintained for a long period of tune.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.